480 Biomedical
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System (NCT02097082) | 480 Biomedical | 2013-10-01 |
| 480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (NCT01403077) | 480 Biomedical | 2011-10-01 |
Track 480 Biomedical automatically
Every clearance here is in the API, with alerts when new ones post.